ImpediMed Limited Stock
Stocks
IPD
AU000000IPD8
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
09:10:09 20/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.005000 AUD | 0.00% |
|
+25.00% | -85.29% |
| 11-18 | ImpediMed Limited - Shareholder/Analyst Call | |
| 10-30 | ImpediMed Limited, Q1 2027 Earnings Call, Oct 30, 2026 |
| Market Cap | 18.31M 12.23M 11.14M 10.31M 9.33M 17.5M 1.14B 125M 49.44M 617M 45.87M 44.91M 1.95B | P/E 2027 * |
-1.25x | P/E 2028 * | -2.5x |
|---|---|---|---|---|---|
| Enterprise Value | 27.61M 18.43M 16.8M 15.55M 14.06M 26.38M 1.72B 188M 74.55M 930M 69.16M 67.71M 2.95B | EV / Sales 2027 * |
1.61x | EV / Sales 2028 * | 1.43x |
| Free-Float |
84.72% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| IPD | Delayed | |
| IPDQF | Delayed | ||
| R1J | Delayed |
Last Transcript: ImpediMed Limited
| 01-30 | Bell Potter rates IPD as Speculative Buy | AQ |
| 01-30 | Morgans rates IPD as Speculative Buy | AQ |
| 10/02/25 | ImpediMed Secures $15m Growth Capital Funding | AQ |
| 05/07/24 | Morgans rates IPD as Add | AQ |
| 01/05/24 | Ord Minnett rates IPD as Speculaitve Buy | AQ |
| 1 week | +25.00% | ||
| Current month | +25.00% | ||
| 1 month | +25.00% | ||
| 6 months | -16.67% | ||
| Current year | -85.29% |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.04 | |
| 1 year | 0 | 0.04 | |
| 3 years | 0 | 0.16 | |
| 5 years | 0 | 0.24 | |
| 10 years | 0 | 1.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Anderson
CEO | Chief Executive Officer | - | 07/05/2026 |
McGregor Grant
DFI | Director of Finance/CFO | - | 20/11/2023 |
Steven Chen
CTO | Chief Tech/Sci/R&D Officer | - | 26/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
McGregor Grant
CHM | Chairman | - | - |
| Chairman | - | 26/02/2024 | |
Janelle Delaney
BRD | Director/Board Member | - | 28/09/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/01/26 | Buy | Chairman | 146,408 | 0.0072% | ||
| 16/01/26 | Buy | Director | 100,563 | 0.0049% | ||
| 16/01/26 | Buy | Director | 100,563 | 0.0049% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +25.00% | -86.49% | -96.15% | 12.23M | ||
| -0.58% | -1.53% | +20.04% | +47.67% | 255B | ||
| -0.45% | -1.98% | +2.32% | +9.52% | 160B | ||
| -3.26% | -7.42% | -27.88% | +33.40% | 141B | ||
| -1.49% | -2.74% | -55.68% | -20.89% | 62.31B | ||
| -1.28% | -1.81% | +20.76% | +55.28% | 59.73B | ||
| -0.05% | +0.05% | +5.92% | -12.43% | 53.49B | ||
| -1.12% | +1.35% | +21.43% | +54.96% | 49.43B | ||
| -2.06% | -1.24% | +21.32% | +74.31% | 44.87B | ||
| -5.15% | -13.06% | -3.69% | +48.93% | 42.57B | ||
| Average | -1.66% | -0.47% | -8.20% | +19.46% | 87B | |
| Weighted average by Cap. | -1.47% | -3.60% | +1.72% | +32.08% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 17.1M 11.42M 10.4M 9.63M 8.71M 16.34M 1.07B 116M 46.17M 576M 42.83M 41.93M 1.83B | 22.5M 15.02M 13.69M 12.67M 11.46M 21.5M 1.4B 153M 60.75M 758M 56.35M 55.17M 2.4B |
| Net income | -16.1M -10.75M -9.79M -9.07M -8.2M -15.38M -1B -110M -43.47M -542M -40.32M -39.48M -1.72B | -9.6M -6.41M -5.84M -5.41M -4.89M -9.17M -599M -65.34M -25.92M -323M -24.04M -23.54M -1.02B |
| Net Debt | 9.3M 6.21M 5.66M 5.24M 4.74M 8.89M 580M 63.29M 25.11M 313M 23.29M 22.8M 993M | 13.89M 9.27M 8.45M 7.82M 7.07M 13.27M 866M 94.51M 37.49M 468M 34.78M 34.05M 1.48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | A$0.005000 | 0.00% | 3,415,758 |
| 19/11/26 | A$0.005000 | 0.00% | 3,367,291 |
| 18/11/26 | A$0.005000 | +25.00% | 5,903,791 |
| 17/11/26 | A$0.004000 | 0.00% | 164,066 |
| 16/11/26 | A$0.004000 | 0.00% | 20,408 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPD Stock
Select your edition
All financial news and data tailored to specific country editions
















